BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jung HY, Jung KC, Shim YH, Ro JY, Kang GH. Methylation of the hMLH1 promoter in multiple gastric carcinomas with microsatellite instability. Pathol Int. 2001;51:445-451. [PMID: 11422806 DOI: 10.1046/j.1440-1827.2001.01222.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Ito T, Suzuki O, Kamae N, Tamaru JI, Arai T, Yamaguchi T, Akagi K, Eguchi H, Okazaki Y, Mochiki E, Ishida H. Comprehensive analysis of DNA mismatch repair-deficient gastric cancer in a Japanese hospital-based population. Jpn J Clin Oncol 2021;51:886-94. [PMID: 33728435 DOI: 10.1093/jjco/hyab026] [Reference Citation Analysis]
2 Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers. Pathol Oncol Res. 2018;24:757-770. [PMID: 29552712 DOI: 10.1007/s12253-018-0410-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
3 Fu DG. Epigenetic alterations in gastric cancer (Review). Mol Med Rep 2015;12:3223-30. [PMID: 25997695 DOI: 10.3892/mmr.2015.3816] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
4 Park HY, Kang SY, Kang GH, Bae GE, Lee SE, Kim K, Park CK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas: EBV and hMLH1 in Multiple Gastric Carcinomas. J Surg Oncol 2012;106:777-82. [DOI: 10.1002/jso.23131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
5 Holmes K, Egan B, Swan N, O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics. 2007;8:379-397. [PMID: 19412438 DOI: 10.2174/138920207783406460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
6 Krasinskas AM, Goldsmith JD. Immunohistology of the Gastrointestinal Tract. Diagnostic Immunohistochemistry 2011. [DOI: 10.1016/b978-1-4160-5766-6.00018-2] [Reference Citation Analysis]
7 Wu Z, Wu L, Weng D, Xu D, Geng J, Zhao F. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J Exp Clin Cancer Res 2009;28:8. [PMID: 19144202 DOI: 10.1186/1756-9966-28-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
8 Ribeiro U Jr, Jorge UM, Safatle-Ribeiro AV, Yagi OK, Scapulatempo C, Perez RO, Corbett CE, Alves VA, Zilberstein B, Gama-Rodrigues J. Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma. J Gastrointest Surg 2007;11:233-9. [PMID: 17458592 DOI: 10.1007/s11605-007-0101-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
9 Liengswangwong U, Karalak A, Morishita Y, Noguchi M, Khuhaprema T, Srivatanakul P, Miwa M. Immunohistochemical expression of mismatch repair genes: A screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2006; 12(23): 3740-3745 [PMID: 16773692 DOI: 10.3748/wjg.v12.i23.3740] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
10 Goldstein NS, Bosler DS. Immunohistochemistry of the Gastrointestinal Tract, Pancreas, Bile Ducts, Gallbladder and Liver. Diagnostic Immunohistochemistry. Elsevier; 2006. pp. 442-508. [DOI: 10.1016/b978-0-443-06652-8.50019-3] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
11 Kim TY, Jong HS, Jung Y, Kim TY, Kang GH, Bang YJ. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004;20 Suppl 1:131-42. [PMID: 15298619 DOI: 10.1111/j.1365-2036.2004.01984.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
12 Vo QN, Geradts J, Boudreau DA, Bravo JC, Schneider BG. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables. Hum Pathol. 2002;33:1200-1204. [PMID: 12514789 DOI: 10.1053/hupa.2002.130108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
13 Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol 2003; 9(1): 26-29 [PMID: 12508345 DOI: 10.3748/wjg.v9.i1.26] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]